cPMP rescue of a neonate with severe molybdenum cofactor deficiency after serendipitous early diagnosis, and characterisation of a novel MOCS1 variant

• Published in: Molecular genetics and metabolism Vol. 143; no. 4; p. 108598
• Main Authors: Schwahn, Bernd C., Hart, Claire, Smith, Louisa Ann, Hart, Anthony, Fairbanks, Lynette, Arenas-Hernandez, Monica, Turner, Charles, Horman, Alistair, Rust, Stewart, Santamaria-Araujo, José A., Mayr, Simon J., Schwarz, Günter, Sharrard, Mark
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01-12-2024
• Subjects: cPMP; Fosdenopterin; Long-term outcome; MOCS1; Molybdenum cofactor deficiency; Sulfite oxidase; Molybdenum cofactor deficiency; Long-term outcome; Sulfite oxidase; MOCS1; cPMP; Fosdenopterin
• ISSN: 1096-7192; 1096-7206; 1096-7206
• DOI: 10.1016/j.ymgme.2024.108598

We report the first, and so far, only index patient with neonatal onset MoCD type A who was diagnosed and treated early enough with cPMP to avoid severe brain injury and disability. The child presented with hypoglycemia at the age of 10 h and was diagnosed because of the incidental finding of severely decreased L-cystine in plasma. Due to a high level of awareness and excellent co-operation between metabolic laboratory and clinical services, cPMP substitution could be initiated before severe encephalopathy set in, and the child subsequently had a normal motor development. The child has been continued on daily substitution with cPMP until today (age 7 years) and has shown a satisfying long-term developmental outcome. Long-term follow-up, however, revealed significant communication difficulties and cognitive abilities in the range of mild to moderate learning disability. The severity of the metabolic disease was confirmed by the extent of biochemical abnormalities and further functional characterisation of the underlying genetic variants. This case provides further evidence that cPMP substitution does significantly alter the disease course when applied early enough. Postnatal treatment in this case was not sufficient to enable an entirely normal cognitive development, despite sustained complete normalization of the biochemical abnormalities.